Mamotest

Mamotest is a health technology company based in Mexico City, Mexico, focused on improving access to breast cancer screening and diagnosis in Latin America.

Founded in 2013, it utilizes artificial intelligence to enhance the accuracy and efficiency of telemammography services. The company connects local health centers with a network of expert radiologists, enabling remote diagnosis and early detection of breast cancer, which is crucial for improving survival rates. With operational centers across Argentina and Mexico, Mamotest has reached over 750,000 patients, providing nearly 90% with access to early, life-saving treatment. The company also emphasizes patient support, offering psychological care and personalized treatment planning. Mamotest is recognized for its innovative approach and is supported by partnerships with organizations like Johnson & Johnson Impact Ventures and the Philips Foundation. Its mission is to democratize healthcare access and reduce breast cancer mortality rates in underserved populations.